Tovinontrine Phase 2 Trial: Lower Doses Cut NT-proBNP
Tovinontrine Phase 2 trial: two of three doses cut NT-proBNP in 529 heart failure patients, but the top dose did not. What it shows and what it does not.
Tovinontrine Phase 2 trial: two of three doses cut NT-proBNP in 529 heart failure patients, but the top dose did not. What it shows and what it does not.